Document is current
Any future updates will be listed below
-
Authors
Benjamin, David J. https://orcid.org/0000-0002-2392-886X
Mita, Alain C.
- License Information
-
More Information
Article History
Accepted: 27 November 2024
First Online: 17 December 2024
Declarations
:
: No external funding was used in the preparation of this manuscript.
: David J. Benjamin has the following disclosures: Consulting/advisory role: AIMED BIO, Astellas, AVEO Oncology, Bayer, Eisai, EMD Serono, Exelixis, and Seagen. Speakers’ bureau: Merck. Travel and accommodations: DAVA Oncology, Merck, and Seagen. Alain C. Mita has the following disclosures: Speakers’ bureau: Genentech. Alain C. Mita is an editorial board member of Targeted Oncology. Alain C. Mita was not involved in the selection of peer reviewers for the manuscript or any of the subsequent editorial decisions.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: DJB—conceptualization, investigation, writing—original draft, writing—review and editing; ACM—writing—original draft, writing—review and editing, supervision.
